[go: up one dir, main page]

SV2004001470A - Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida ref. pc11901 - Google Patents

Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida ref. pc11901

Info

Publication number
SV2004001470A
SV2004001470A SV2003001470A SV2003001470A SV2004001470A SV 2004001470 A SV2004001470 A SV 2004001470A SV 2003001470 A SV2003001470 A SV 2003001470A SV 2003001470 A SV2003001470 A SV 2003001470A SV 2004001470 A SV2004001470 A SV 2004001470A
Authority
SV
El Salvador
Prior art keywords
zoniporida
mesilate
ref
solubility
procedures
Prior art date
Application number
SV2003001470A
Other languages
English (en)
Inventor
Daniel Ray Arenson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2004001470A publication Critical patent/SV2004001470A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

FORMULACIONES QUE CONTIENEN UN INHIBIDOR DEL INTERCAMBIADOR -1 DE SODIO E HIDROGENO (NHE-1) PARA LA PREVENCION, ENTRE OTRAS, DE LA LESION ISQUEMICA PERIOPERATORIA DE MIOCARDIO EN LOS MAMIFEROS Y UN PROCEDIMIENTO PARA AUMENTAR LA SOLUBILIDAD DE DICHO INHIBIDOR CON ACIDO METANOSULFONICO
SV2003001470A 2002-01-30 2003-01-29 Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida ref. pc11901 SV2004001470A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35302502P 2002-01-30 2002-01-30

Publications (1)

Publication Number Publication Date
SV2004001470A true SV2004001470A (es) 2004-05-07

Family

ID=27663165

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2003001470A SV2004001470A (es) 2002-01-30 2003-01-29 Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida ref. pc11901

Country Status (16)

Country Link
US (1) US20030149075A1 (es)
EP (1) EP1472242A1 (es)
JP (1) JP2005521670A (es)
AR (1) AR038322A1 (es)
BR (1) BR0307195A (es)
CA (1) CA2472342A1 (es)
DO (1) DOP2003000569A (es)
GT (1) GT200300012A (es)
HN (1) HN2003000050A (es)
MX (1) MXPA04006615A (es)
PA (1) PA8564501A1 (es)
PE (1) PE20030817A1 (es)
SV (1) SV2004001470A (es)
TW (1) TW200302721A (es)
UY (1) UY27624A1 (es)
WO (1) WO2003064409A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3672571T (lt) 2017-08-25 2021-12-10 Pfizer Inc. Farmacinė vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia
UA72002C2 (en) * 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
WO2003064409A1 (en) 2003-08-07
UY27624A1 (es) 2003-08-29
EP1472242A1 (en) 2004-11-03
HN2003000050A (es) 2003-08-22
PE20030817A1 (es) 2003-10-04
DOP2003000569A (es) 2003-08-15
BR0307195A (pt) 2004-11-03
US20030149075A1 (en) 2003-08-07
AR038322A1 (es) 2005-01-12
PA8564501A1 (es) 2003-09-17
GT200300012A (es) 2003-08-28
MXPA04006615A (es) 2004-10-04
CA2472342A1 (en) 2003-08-07
TW200302721A (en) 2003-08-16
JP2005521670A (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
UY27516A1 (es) Bencimidazoles
SV2008001369A (es) Benzimidazoles
DOP2003000566A (es) Cicloalcanindoles con sustitución con fluor, composiciones que contienen estos compuestos y metodos de preparación para un medicamento
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
PA8462301A1 (es) Combinacion de un inhibidor de la aldosa reductasa y un inhibidor de la glucogeno fosforilasa
ECSP003682A (es) Compuestos para el tratamiento de la isquemia
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
PA8503601A1 (es) Derivados de purina
GT200000005A (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer.
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
AR023129A1 (es) Composiciones para mejorar la fertilidad
HN1999000106A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
ES2136037A1 (es) Inhibidores de sulfamida-metaloproteasa
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
AR034120A1 (es) Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
AR041339A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR050260A1 (es) Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion
SV2004001470A (es) Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida ref. pc11901
SV1997000033A (es) Derivados de acido 4-arilbutirico sustituido como inhibisor de matriz de metaloproteasa

Legal Events

Date Code Title Description
FD Lapse